DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study

Information source: Duke University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Type II Diabetes

Intervention: Personalized Health Planning Shared Medical Appointment (Behavioral)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Duke University

Official(s) and/or principal investigator(s):
Sharon Hull, MD MPH, Principal Investigator, Affiliation: Duke University

Overall contact:
Connor D Drake, MPA, Phone: 9197242129, Email: connor.drake@duke.edu


The primary aim of this study is to examine the feasibility of implementing an evidence based patient engagement strategy, known as personalized health planning (PHP), in the context of a a shared medical appointment (SMA) for individuals with type II diabetes in a primary care setting.

Clinical Details

Official title: Personalized Health Planning in Shared Medical Appointments for Individuals With Type II

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome:

Feasibility measured using a patient satisfaction survey

Change in patient activation measured using the patient activation measure

Change in self-management of diabetes self-efficacy using the Diabetes Empowerment Scale

Change in diabetes self efficacy using the 1-item diabetes self-efficacy scale

Change in A1C using the A1C blood test

Secondary outcome:

Change in depression screening score using the Patient Health Questionnaire (PHQ-9)

Change in functional health and well-being using the short form health survey

Change in general self-rated health using the general self rated health survey (GSRH)

Change in health goal progress using a goal progress visual analog scale

change in body mass index using weight and height measurements

change in blood pressure using blood pressure measurement

Change in low-density lipoprotein cholesterol (LDL) using LDL measurement


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- A diagnosis of Type 2 diabetes within the last year

- A current patient at Duke Family Medicine.

- An A1C score greater than 7 and less than 14.

Exclusion Criteria:

- A diagnosis of Pre-diabetes

- A diagnosis of Type I diabetes

- Individuals with amputations as a result of their diabetes are excluded form this


- Individuals with renal dialysis will not be included in this study.

Locations and Contacts

Connor D Drake, MPA, Phone: 9197242129, Email: connor.drake@duke.edu

Additional Information

Starting date: August 2015
Last updated: June 11, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017